Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Inogen Inc (INGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "TRANSITION AGREEMENT AND RELEASE This Transition Agreement and Release is made by and between George Parr and Inogen, Inc. as of July 31, 2023 . WHEREAS, Employee signed an At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement with the Company dated April 5, 2021 ; WHEREAS, Employee has been employed at-will by the Company pursuant to the terms and conditions of the Employment Agreement and other agreements completed on his first day of employment on April 12, 2021; WHEREAS, Employee previously was granted awards of some or all of stock options, restricted stock, restricted stock units, performance restricted stock, and performance stock units in each case, that are outstanding as of the date hereof subject to the terms and conditions of the applica..."
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Quarterly results
Docs: "Consolidated Statements of Comprehensive Loss Three months ended Six months ended June 30, June 30, 2023 2022 2023 2022 Revenue Sales revenue $ 68,343 $ 89,291 $ 124,230 $ 156,693 Rental revenue 15,292 14,085 31,567 27,068 Total revenue 83,635 103,376 155,797 183,761 Cost of revenue Cost of sales revenue 42,028 50,661 75,992 90,161 Cost of rental revenue, including depreciation of $3,238 and $2,720 for the three months ended and $6,316 and $5,358 for the six months ended, respectively 7,563 6,457 15,028 12,336 Total cost of revenue 49,591 57,118 91,020 102,497 Gross profit 34,044 46,258 64,777 81,264 Operating expense Research and development 4,293 6,064 9,637 11,428 Sales and marketing 26,906 30,388 55,347 58,427 General and administrative 14,613 12,682 33,476 27,871 Total operating expe..."
07/31/2023 8-K Quarterly results
07/24/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/18/2023 8-K Quarterly results
07/13/2023 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Financia...
Docs: "10 JULY 2023 Between Mr. Adrien MITHALAL Mr. Jean-Sébastien LANTZ Mrs. Anne REISER CAAP CREATION SOCIETE DE CAPITAL RISQUE PROVENCALE ET CORSE REGION SUD INVESTISSEMENT Mérieux Participations 2 Relyens Innovation Santé the holders of Exercisable Securities listed in Schedule A As the Sellers And Inogen, Inc. As the Purchaser In the presence of Physio-Assist As the Company SHARE PURCHASE AGREEMENT",
"TERMS AND CONDITIONS OF CONVERTIBLE BONDS"
07/10/2023 SC 13G/A VANGUARD GROUP INC reports a 6.4% stake in Inogen Inc.
07/07/2023 SC 13G/A BlackRock Inc. reports a 7.5% stake in INOGEN INC
06/06/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/05/2023 4 Somer Jason (EVP, Gen. Counsel & Secretary) has filed a Form 4 on Inogen Inc
Txns: Paid exercise price by delivering 286 shares @ $10.37, valued at $3k
Exercised 576 restricted stock units @ $0
06/05/2023 4 Shabshab Nabil (CEO and President) has filed a Form 4 on Inogen Inc
Txns: Paid exercise price by delivering 1,941 shares @ $10.37, valued at $20.1k
Exercised 1,568 restricted stock units @ $0
Exercised 2,117 restricted stock units @ $0
06/02/2023 4 West Thomas A. (Director) has filed a Form 4 on Inogen Inc
Txns: Granted 17,094 shares @ $0
06/02/2023 4 Rider Heather D. (Director) has filed a Form 4 on Inogen Inc
Txns: Granted 17,094 shares @ $0
06/02/2023 4 Mora Elizabeth (Director) has filed a Form 4 on Inogen Inc
Txns: Granted 17,094 shares @ $0
06/02/2023 4 Ladone Mary Kay (Director) has filed a Form 4 on Inogen Inc
Txns: Granted 17,094 shares @ $0
06/02/2023 4 King Kevin M (Director) has filed a Form 4 on Inogen Inc
Txns: Granted 17,094 shares @ $0
06/02/2023 4 Boehnlein Glenn S (Director) has filed a Form 4 on Inogen Inc
Txns: Granted 17,094 shares @ $0
05/30/2023 SD Form SD - Specialized disclosure report:
05/11/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/04/2023 8-K Quarterly results
04/18/2023 ARS Form ARS - Annual Report to Security Holders:
04/18/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/18/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/04/2023 4 West Thomas A. (Director) has filed a Form 4 on Inogen Inc
Txns: Granted 1,712 shares @ $0
04/04/2023 3 West Thomas A. (Director) has filed a Form 3 on Inogen Inc
03/22/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Inogen Announces Appointment of Tom West to Board of Directors and Retirement of Board Member Kristen Miranda"
03/02/2023 4 Sanford Bart Ben (EVP, Operations) has filed a Form 4 on Inogen Inc
Txns: Granted 1,135 shares @ $0
Paid exercise price by delivering 507 shares @ $15.56, valued at $7.9k
Paid exercise price by delivering 1,166 shares @ $15.56, valued at $18.1k
Exercised 273 restricted stock units @ $0
Exercised 236 restricted stock units @ $0
Exercised 1,893 restricted stock units @ $0
03/02/2023 4 Somer Jason (EVP, Gen. Counsel & Secretary) has filed a Form 4 on Inogen Inc
Txns: Granted 1,135 shares @ $0
Paid exercise price by delivering 634 shares @ $15.56, valued at $9.9k
Paid exercise price by delivering 1,378 shares @ $15.56, valued at $21.4k
Exercised 577 restricted stock units @ $0
Exercised 1,893 restricted stock units @ $0
Granted 14,039 restricted stock units @ $0
03/02/2023 4 Glezer Stanislav (EVP, Chief Technology Officer) has filed a Form 4 on Inogen Inc
Txns: Granted 2,272 shares @ $0
Paid exercise price by delivering 1,142 shares @ $15.56, valued at $17.8k
Paid exercise price by delivering 2,568 shares @ $15.56, valued at $40k
Exercised 769 restricted stock units @ $0
Exercised 3,787 restricted stock units @ $0
Granted 28,079 restricted stock units @ $0
03/02/2023 4 Parr George J (Chief Commercial Officer) has filed a Form 4 on Inogen Inc
Txns: Granted 2,272 shares @ $0
Paid exercise price by delivering 988 shares @ $15.56, valued at $15.4k
Paid exercise price by delivering 2,411 shares @ $15.56, valued at $37.5k
Exercised 1,126 restricted stock units @ $0
Exercised 3,787 restricted stock units @ $0
Granted 28,079 restricted stock units @ $0
03/02/2023 4 Caltrider Kristin A. (EVP, CFO and Treasurer) has filed a Form 4 on Inogen Inc
Txns: Paid exercise price by delivering 6,231 shares @ $15.56, valued at $97k
Exercised 11,360 restricted stock units @ $0
Granted 28,079 restricted stock units @ $0
03/02/2023 4 Shabshab Nabil (CEO and President) has filed a Form 4 on Inogen Inc
Txns: Granted 7,810 shares @ $0
Paid exercise price by delivering 3,873 shares @ $15.56, valued at $60.3k
Paid exercise price by delivering 8,362 shares @ $15.56, valued at $130.1k
Exercised 1,568 restricted stock units @ $0
Exercised 2,117 restricted stock units @ $0
Exercised 13,017 restricted stock units @ $0
Granted 70,197 restricted stock units @ $0
02/24/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy